Benjamin F. Edwards & Company, Inc. Ishares Tr Genomics Immunology Transaction History

Benjamin F. Edwards & Company, Inc.

  • $5.51 Billion
  • Q1 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 1,473 shares of IDNA stock, worth $34,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,473
Previous 1,595 7.65%
Holding current value
$34,055
Previous $37,000 5.41%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
SELL
$22.28 - $25.2 $2,718 - $3,074
-122 Reduced 7.65%
1,473 $35,000
Q4 2023

Feb 06, 2024
SELL
$17.37 - $23.3 $3,804 - $5,102
-219 Reduced 12.07%
1,595 $37,000
Q2 2023

Aug 15, 2023
BUY
$23.05 - $25.1 $5,393 - $5,873
234 Added 14.81%
1,814 $42,000
Q1 2023

Apr 27, 2023
BUY
$22.48 - $27.9 $35,518 - $44,082
1,580 New
1,580 $37,000

Others Institutions Holding IDNA

# of Institutions
66
Shares Held
1.84M
Call Options Held
0
Put Options Held
0
View Full List

About ISHARES TR GENOMICS IMMUNOLOGY

IDNA Quotes by TradingView
  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email